OPTIMISATION OF INTRACAMERAL CEFUROXIME CONSUMPTION IN THE PREVENTION OF POSTOPERATIVE ENDOPHTALMITIS
3PC-060
HOT-MELT RAM EXTRUSION 3D PRINTING: A SMART METHOD FOR COMPOUNDING ORODISPERSIBLE FILMS IN HOSPITAL PHARMACIES
3PC-059
USE OF EXTEMPORANEOUS ORAL SUSPENSIONS OF OXYBUTININ AND PRAZOSINE IN NEONATES
3PC-058
ROBOTIC COMPOUNDING: SAFETY AND PRODUCTIVITY ACHIEVEMENTS IN THE PREPARATION OF HAZARDOUS DRUGS
3PC-057
ECONOMIC IMPACT AFTER THE IMPLEMENTATION OF A RISK MATRIX IN THE PREPARATION OF CHEMOTHERAPY
3PC-056
PERFORMANCE ANALYSIS OF A FULLY AUTOMATED ONCOLOGY PHARMACY PRODUCTION: A 2018 UPDATE
3PC-055
CYTOTOXIC AGENTS: SKIN TESTS FOR THE DIAGNOSIS OF DRUG HYPERSENSITIVITY
3PC-054
ADDED VALUE FROM AN INFORMATION AND COMMUNICATION TECHNOLOGY-ASSISTED INTERVENTION IN A TOTAL PARENTERAL UNIT OF A PAEDIATRIC HOSPITAL PHARMACY
3PC-053
NEW FORMULATIONS FOR THE TREATMENT OF ANTINEOPLASTIC AND RADIOTHERAPY-INDUCED MUCOSITES
3PC-052
CHEMICAL DISINFECTANTS VS STERILE WATER AND COMPOSITE FIBRE: THE EFFECT OF CLEANING METHODS ON MICROBIAL CONTAMINATION IN A CLASS A PHARMACEUTICAL COMPOUNDING ENVIRONMENT
3PC-051
IMPACT OF OPHTHALMOLOGICAL PREPARATIONS IN THE PHARMACY SERVICE OF A REFERENCE HOSPITAL
3PC-050
APPLICATION OF HAZARD VULNERABILITY ANALYSIS TO EVALUATE POTENTIAL RISKS OF PHARMACY COMPOUNDING
3PC-049
MOBILE APPLICATIONS RELATED TO PARENTERAL NUTRITION: QUALITATIVE AND QUANTITATIVE ANALYSIS
3PC-048
ORAL MUCOADHESIVE DEXAMETHASONE 0.1% (M / M) GEL: A STRATEGY FOR MOTOR INHIBITORS MUCOSITIS
